Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 366

1.

Assessment of plasma creatine kinase as biomarker for levodopa-induced dyskinesia in Parkinson's disease.

Delamarre A, Tison F, Li Q, Galitzky M, Rascol O, Bezard E, Meissner WG.

J Neural Transm (Vienna). 2019 Jun;126(6):789-793. doi: 10.1007/s00702-019-02015-x. Epub 2019 May 16.

PMID:
31098725
2.

Bismuth Concentrations in Patients Treated in Real-Life Practice with a Bismuth Subcitrate-Metronidazole-Tetracycline Preparation: The SAPHARY Study.

Guiard E, Lelievre B, Rouyer M, Zerbib F, Diquet B, Mégraud F, Tison F, Bignon E, Lassalle R, Droz-Perroteau C, Moore N, Blin P.

Drug Saf. 2019 May 8. doi: 10.1007/s40264-019-00821-6. [Epub ahead of print]

PMID:
31069703
3.

Functional classification of ATM variants in ataxia-telangiectasia patients.

Fiévet A, Bellanger D, Rieunier G, Dubois d'Enghien C, Sophie J, Calvas P, Carriere JP, Anheim M, Castrioto A, Flabeau O, Degos B, Ewenczyk C, Mahlaoui N, Touzot F, Suarez F, Hully M, Roubertie A, Aladjidi N, Tison F, Antoine-Poirel H, Dahan K, Doummar D, Nougues MC, Ioos C, Rougeot C, Masurel A, Bourjault C, Ginglinger E, Prieur F, Siri A, Bordigoni P, Nguyen K, Philippe N, Bellesme C, Demeocq F, Altuzarra C, Mathieu-Dramard M, Couderc F, Dörk T, Auger N, Parfait B, Abidallah K, Moncoutier V, Collet A, Stoppa-Lyonnet D, Stern MH.

Hum Mutat. 2019 May 3. doi: 10.1002/humu.23778. [Epub ahead of print]

PMID:
31050087
4.

Evolution of brain atrophy subtypes during aging predicts long-term cognitive decline and future Alzheimer's clinical syndrome.

Planche V, Coupé P, Helmer C, Le Goff M, Amieva H, Tison F, Dartigues JF, Catheline G.

Neurobiol Aging. 2019 Mar 22;79:22-29. doi: 10.1016/j.neurobiolaging.2019.03.006. [Epub ahead of print]

PMID:
31026619
5.

Dopamine transporter imaging for the diagnosis of multiple system atrophy cerebellar type.

Vergnet S, Hives F, Foubert-Samier A, Payoux P, Fernandez P, Meyer M, Dupouy J, Brefel-Courbon C, Ory-Magne F, Rascol O, Tison F, Pavy-Le Traon A, Meissner WG.

Parkinsonism Relat Disord. 2019 Feb 5. pii: S1353-8020(19)30037-9. doi: 10.1016/j.parkreldis.2019.02.006. [Epub ahead of print]

PMID:
30745212
6.

Acute toxic limbic encephalopathy following glyphosate intoxication.

Planche V, Vergnet S, Auzou N, Bonnet M, Tourdias T, Tison F.

Neurology. 2019 Mar 12;92(11):534-536. doi: 10.1212/WNL.0000000000007115. Epub 2019 Feb 8. No abstract available.

PMID:
30737339
7.

Clinical Rating Scales for Urinary Symptoms in Parkinson Disease: Critique and Recommendations.

Pavy-Le Traon A, Cotterill N, Amarenco G, Duerr S, Kaufmann H, Lahrmann H, Tison F, Wenning GK, Goetz CG, Poewe W, Sampaio C, Schrag A, Rascol O, Martinez-Martin P, Stebbins GT; Members of the MDS Committee on Rating Scales Development.

Mov Disord Clin Pract. 2018 Oct 25;5(5):479-491. doi: 10.1002/mdc3.12636. eCollection 2018 Sep-Oct. Review.

PMID:
30515437
8.

Prodromal Alzheimer's Disease Demonstrates Increased Errors at a Simple and Automated Anti-Saccade Task.

Holden JG, Cosnard A, Laurens B, Asselineau J, Biotti D, Cubizolle S, Dupouy S, Formaglio M, Koric L, Seassau M, Tilikete C, Vighetto A, Tison F.

J Alzheimers Dis. 2018;65(4):1209-1223. doi: 10.3233/JAD-180082.

PMID:
30149445
9.

Deep brain stimulation does not enhance neuroinflammation in multiple system atrophy.

Lopez-Cuina M, Fernagut PO, Canron MH, Vital A, Lannes B, De Paula AM, Streichenberger N, Guehl D, Damier P, Eusebio A, Houeto JL, Tison F, Tranchant C, Viallet F, Witjas T, Thobois S, Meissner WG.

Neurobiol Dis. 2018 Oct;118:155-160. doi: 10.1016/j.nbd.2018.07.016. Epub 2018 Jul 17.

PMID:
30026036
10.

Are visual cues helpful for virtual spatial navigation and spatial memory in patients with mild cognitive impairment or Alzheimer's disease?

Cogné M, Auriacombe S, Vasa L, Tison F, Klinger E, Sauzéon H, Joseph PA, N Kaoua B.

Neuropsychology. 2018 May;32(4):385-400. doi: 10.1037/neu0000435.

PMID:
29809030
11.

Present and future of disease-modifying therapies in multiple system atrophy.

Lopez-Cuina M, Foubert-Samier A, Tison F, Meissner WG.

Auton Neurosci. 2018 May;211:31-38. doi: 10.1016/j.autneu.2017.12.008. Epub 2018 Jan 4. Review.

PMID:
29311010
12.

L-DOPA-induced dyskinesias, motor fluctuations and health-related quality of life: the COPARK survey.

Perez-Lloret S, Negre-Pages L, Damier P, Delval A, Derkinderen P, Destée A, Meissner WG, Tison F, Rascol O; of the COPARK Study Group.

Eur J Neurol. 2017 Dec;24(12):1532-1538. doi: 10.1111/ene.13466. Epub 2017 Oct 9.

PMID:
28940893
13.

A panel study on patients with dominant cerebellar ataxia highlights the frequency of channelopathies.

Coutelier M, Coarelli G, Monin ML, Konop J, Davoine CS, Tesson C, Valter R, Anheim M, Behin A, Castelnovo G, Charles P, David A, Ewenczyk C, Fradin M, Goizet C, Hannequin D, Labauge P, Riant F, Sarda P, Sznajer Y, Tison F, Ullmann U, Van Maldergem L, Mochel F, Brice A, Stevanin G, Durr A; SPATAX network.

Brain. 2017 Jun 1;140(6):1579-1594. doi: 10.1093/brain/awx081.

PMID:
28444220
14.

Multiple System Atrophy - State of the Art.

Laurens B, Vergnet S, Lopez MC, Foubert-Samier A, Tison F, Fernagut PO, Meissner WG.

Curr Neurol Neurosci Rep. 2017 May;17(5):41. doi: 10.1007/s11910-017-0751-0. Review.

PMID:
28378233
15.

Characteristics in limbic encephalitis with anti-adenylate kinase 5 autoantibodies.

Do LD, Chanson E, Desestret V, Joubert B, Ducray F, Brugière S, Couté Y, Formaglio M, Rogemond V, Thomas-Antérion C, Borrega L, Laurens B, Tison F, Curot J, De Brouker T, Lebrun-Frenay C, Delattre JY, Antoine JC, Honnorat J.

Neurology. 2017 Feb 7;88(6):514-524. doi: 10.1212/WNL.0000000000003586. Epub 2017 Jan 6.

PMID:
28062719
16.

Impact of sleep apnea syndrome on survival in patients with multiple system atrophy.

Flabeau O, Ghorayeb I, Perez P, Maillard A, Taillard J, Philip P, Foubert-Samier A, Tison F, Meissner WG.

Parkinsonism Relat Disord. 2017 Feb;35:92-95. doi: 10.1016/j.parkreldis.2016.12.013. Epub 2016 Dec 16.

PMID:
28011164
17.

Trends in Prevalence of Dementia in French Farmers from Two Epidemiological Cohorts.

Pérès K, Brayne C, Matharan F, Grasset L, Helmer C, Letenneur L, Foubert-Samier A, Baldi I, Tison F, Amieva H, Dartigues JF.

J Am Geriatr Soc. 2017 Feb;65(2):415-420. doi: 10.1111/jgs.14575. Epub 2016 Dec 19.

PMID:
27991652
18.

French consensus procedure for assessing cognitive function in Parkinson's disease.

Dujardin K, Auzou N, Lhommée E, Czernecki V, Dubois B, Fradet A, Maltete D, Meyer M, Pineau F, Schmitt E, Sellal F, Tison F, Vidal T, Azulay JP, Welter ML, Corvol JC, Durif F, Rascol O; NS-Park network.

Rev Neurol (Paris). 2016 Nov;172(11):696-702. doi: 10.1016/j.neurol.2016.05.001. Epub 2016 Jun 16.

PMID:
27318613
19.

A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease.

Tison F, Keywood C, Wakefield M, Durif F, Corvol JC, Eggert K, Lew M, Isaacson S, Bezard E, Poli SM, Goetz CG, Trenkwalder C, Rascol O.

Mov Disord. 2016 Sep;31(9):1373-80. doi: 10.1002/mds.26659. Epub 2016 May 23.

PMID:
27214664
20.

How Health Professionals Conceptualize and Represent Placebo Treatment in Clinical Trials and How Their Patients Understand It: Impact on Validity of Informed Consent.

Keller PH, Grondin O, Tison F, Gonon F.

PLoS One. 2016 May 19;11(5):e0155940. doi: 10.1371/journal.pone.0155940. eCollection 2016.

21.

Loss-of-function mutations in RAB39B are associated with typical early-onset Parkinson disease.

Lesage S, Bras J, Cormier-Dequaire F, Condroyer C, Nicolas A, Darwent L, Guerreiro R, Majounie E, Federoff M, Heutink P, Wood NW, Gasser T, Hardy J, Tison F, Singleton A, Brice A; French Parkinson's Disease Genetics Study Group (PDG) and the International Parkinson's Disease Genomics Consortium (IPDGC).

Neurol Genet. 2015 Jun 18;1(1):e9. doi: 10.1212/NXG.0000000000000009. eCollection 2015 Jun.

22.

Impact of Mood and Behavioral Disorders on Quality of Life in Parkinson's disease.

Rieu I, Houeto JL, Pereira B, De Chazeron I, Bichon A, Chéreau I, Ulla M, Brefel-Courbon C, Ory-Magne F, Dujardin K, Tison F, Krack P, Durif F.

J Parkinsons Dis. 2016;6(1):267-77. doi: 10.3233/JPD-150747.

PMID:
27003781
23.

Loss of VPS13C Function in Autosomal-Recessive Parkinsonism Causes Mitochondrial Dysfunction and Increases PINK1/Parkin-Dependent Mitophagy.

Lesage S, Drouet V, Majounie E, Deramecourt V, Jacoupy M, Nicolas A, Cormier-Dequaire F, Hassoun SM, Pujol C, Ciura S, Erpapazoglou Z, Usenko T, Maurage CA, Sahbatou M, Liebau S, Ding J, Bilgic B, Emre M, Erginel-Unaltuna N, Guven G, Tison F, Tranchant C, Vidailhet M, Corvol JC, Krack P, Leutenegger AL, Nalls MA, Hernandez DG, Heutink P, Gibbs JR, Hardy J, Wood NW, Gasser T, Durr A, Deleuze JF, Tazir M, Destée A, Lohmann E, Kabashi E, Singleton A, Corti O, Brice A; French Parkinson's Disease Genetics Study (PDG); International Parkinson's Disease Genomics Consortium (IPDGC).

Am J Hum Genet. 2016 Mar 3;98(3):500-513. doi: 10.1016/j.ajhg.2016.01.014.

24.

Outcome of deep brain stimulation in slowly progressive multiple system atrophy: A clinico-pathological series and review of the literature.

Meissner WG, Laurencin C, Tranchant C, Witjas T, Viallet F, Guehl D, Damier P, Houeto JL, Tison F, Eusebio A, Vital A, Streichenberger N, Lannes B, Maues de Paula A, Thobois S.

Parkinsonism Relat Disord. 2016 Mar;24:69-75. doi: 10.1016/j.parkreldis.2016.01.005. Epub 2016 Jan 7. Review.

PMID:
26778473
25.

Subjective sleep dysfunction and insomnia symptoms in Parkinson's disease: Insights from a cross-sectional evaluation of the French CoPark cohort.

Ratti PL, Nègre-Pagès L, Pérez-Lloret S, Manni R, Damier P, Tison F, Destée A, Rascol O.

Parkinsonism Relat Disord. 2015 Nov;21(11):1323-9. doi: 10.1016/j.parkreldis.2015.09.025. Epub 2015 Sep 10.

PMID:
26411501
26.

Delayed-onset Friedreich's ataxia revisited.

Lecocq C, Charles P, Azulay JP, Meissner W, Rai M, N'Guyen K, Péréon Y, Fabre N, Robin E, Courtois S, Guyant-Maréchal L, Zagnoli F, Rudolf G, Renaud M, Sévin-Allouet M, Lesne F, Alaerts N, Goizet C, Calvas P, Eusebio A, Guissart C, Derkinderen P, Tison F, Brice A, Koenig M, Pandolfo M, Tranchant C, Dürr A, Anheim M.

Mov Disord. 2016 Jan;31(1):62-9. doi: 10.1002/mds.26382. Epub 2015 Sep 21.

PMID:
26388117
27.

Diagnosing dementia in multiple system atrophy by applying Movement Disorder Society diagnostic criteria for Parkinson's disease dementia.

Auzou N, Dujardin K, Biundo R, Foubert-Samier A, Barth C, Duval F, Tison F, Defebvre L, Antonini A, Meissner WG.

Parkinsonism Relat Disord. 2015 Oct;21(10):1273-7. doi: 10.1016/j.parkreldis.2015.08.013. Epub 2015 Aug 14.

PMID:
26305998
28.

Region-Specific Alterations of Matrix Metalloproteinase Activity in Multiple System Atrophy.

Bassil F, Monvoisin A, Canron MH, Vital A, Meissner WG, Tison F, Fernagut PO.

Mov Disord. 2015 Nov;30(13):1802-12. doi: 10.1002/mds.26329. Epub 2015 Aug 11.

PMID:
26260627
29.

Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease.

Bastide MF, Meissner WG, Picconi B, Fasano S, Fernagut PO, Feyder M, Francardo V, Alcacer C, Ding Y, Brambilla R, Fisone G, Jon Stoessl A, Bourdenx M, Engeln M, Navailles S, De Deurwaerdère P, Ko WK, Simola N, Morelli M, Groc L, Rodriguez MC, Gurevich EV, Quik M, Morari M, Mellone M, Gardoni F, Tronci E, Guehl D, Tison F, Crossman AR, Kang UJ, Steece-Collier K, Fox S, Carta M, Angela Cenci M, Bézard E.

Prog Neurobiol. 2015 Sep;132:96-168. doi: 10.1016/j.pneurobio.2015.07.002. Epub 2015 Jul 21. Review.

PMID:
26209473
30.

New insights into orthostatic hypotension in multiple system atrophy: a European multicentre cohort study.

Pavy-Le Traon A, Piedvache A, Perez-Lloret S, Calandra-Buonaura G, Cochen-De Cock V, Colosimo C, Cortelli P, Debs R, Duerr S, Fanciulli A, Foubert-Samier A, Gerdelat A, Gurevich T, Krismer F, Poewe W, Tison F, Tranchant C, Wenning G, Rascol O, Meissner WG; European MSA Study Group.

J Neurol Neurosurg Psychiatry. 2016 May;87(5):554-61. doi: 10.1136/jnnp-2014-309999. Epub 2015 May 14.

PMID:
25977316
31.

Mutations in XPR1 cause primary familial brain calcification associated with altered phosphate export.

Legati A, Giovannini D, Nicolas G, López-Sánchez U, Quintáns B, Oliveira JR, Sears RL, Ramos EM, Spiteri E, Sobrido MJ, Carracedo Á, Castro-Fernández C, Cubizolle S, Fogel BL, Goizet C, Jen JC, Kirdlarp S, Lang AE, Miedzybrodzka Z, Mitarnun W, Paucar M, Paulson H, Pariente J, Richard AC, Salins NS, Simpson SA, Striano P, Svenningsson P, Tison F, Unni VK, Vanakker O, Wessels MW, Wetchaphanphesat S, Yang M, Boller F, Campion D, Hannequin D, Sitbon M, Geschwind DH, Battini JL, Coppola G.

Nat Genet. 2015 Jun;47(6):579-81. doi: 10.1038/ng.3289. Epub 2015 May 4.

32.

Falls in ambulatory non-demented patients with Parkinson's disease.

Rascol O, Perez-Lloret S, Damier P, Delval A, Derkinderen P, Destée A, Meissner WG, Tison F, Negre-Pages L.

J Neural Transm (Vienna). 2015 Oct;122(10):1447-55. doi: 10.1007/s00702-015-1396-2. Epub 2015 Apr 7.

PMID:
25845678
33.

International validation of a behavioral scale in Parkinson's disease without dementia.

Rieu I, Martinez-Martin P, Pereira B, De Chazeron I, Verhagen Metman L, Jahanshahi M, Ardouin C, Chéreau I, Brefel-Courbon C, Ory-Magne F, Klinger H, Peyrol F, Schupbach M, Dujardin K, Tison F, Houeto JL, Krack P, Durif F.

Mov Disord. 2015 Apr 15;30(5):705-13. doi: 10.1002/mds.26223. Epub 2015 Mar 21.

PMID:
25809278
34.

Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson's disease.

Moreau C, Meguig S, Corvol JC, Labreuche J, Vasseur F, Duhamel A, Delval A, Bardyn T, Devedjian JC, Rouaix N, Petyt G, Brefel-Courbon C, Ory-Magne F, Guehl D, Eusebio A, Fraix V, Saulnier PJ, Lagha-Boukbiza O, Durif F, Faighel M, Giordana C, Drapier S, Maltête D, Tranchant C, Houeto JL, Debû B, Azulay JP, Tison F, Destée A, Vidailhet M, Rascol O, Dujardin K, Defebvre L, Bordet R, Sablonnière B, Devos D; Parkgait-II Study Group.

Brain. 2015 May;138(Pt 5):1271-83. doi: 10.1093/brain/awv063. Epub 2015 Mar 23.

35.

Current Concepts in the Treatment of Multiple System Atrophy.

Perez-Lloret S, Flabeau O, Fernagut PO, Pavy-Le Traon A, Rey MV, Foubert-Samier A, Tison F, Rascol O, Meissner WG.

Mov Disord Clin Pract. 2015 Feb 2;2(1):6-16. doi: 10.1002/mdc3.12145. eCollection 2015 Mar. Review.

36.

The mGluR5 negative allosteric modulator dipraglurant reduces dyskinesia in the MPTP macaque model.

Bezard E, Pioli EY, Li Q, Girard F, Mutel V, Keywood C, Tison F, Rascol O, Poli SM.

Mov Disord. 2014 Jul;29(8):1074-9. doi: 10.1002/mds.25920. Epub 2014 May 27.

PMID:
24865335
37.

Prevalence, determinants, and effect on quality of life of freezing of gait in Parkinson disease.

Perez-Lloret S, Negre-Pages L, Damier P, Delval A, Derkinderen P, Destée A, Meissner WG, Schelosky L, Tison F, Rascol O.

JAMA Neurol. 2014 Jul 1;71(7):884-90. doi: 10.1001/jamaneurol.2014.753.

PMID:
24839938
38.

Restless legs syndrome in multiple system atrophy.

Ghorayeb I, Dupouy S, Tison F, Meissner WG.

J Neural Transm (Vienna). 2014 Dec;121(12):1523-7. doi: 10.1007/s00702-014-1232-0. Epub 2014 May 13.

PMID:
24818598
39.

Multiple system atrophy: a prototypical synucleinopathy for disease-modifying therapeutic strategies.

Fernagut PO, Dehay B, Maillard A, Bezard E, Perez P, Pavy-Le Traon A, Rascol O, Foubert-Samier A, Tison F, Meissner WG.

Neurobiol Dis. 2014 Jul;67:133-9. doi: 10.1016/j.nbd.2014.03.021. Epub 2014 Apr 12. Review.

PMID:
24727096
40.

A cross-sectional study on drug use in multiple system atrophy.

Rey MV, Perez-Lloret S, Pavy-Le Traon A, Meissner WG, Tison F, Rascol O.

CNS Drugs. 2014 May;28(5):483-90. doi: 10.1007/s40263-014-0159-1.

PMID:
24683045
41.

Accuracy of portable polygraphy for the diagnosis of sleep apnea in multiple system atrophy.

Meissner WG, Flabeau O, Perez P, Taillard J, Marquant F, Dupouy S, Tison F, Philip P, Ghorayeb I.

Sleep Med. 2014 Apr;15(4):476-9. doi: 10.1016/j.sleep.2013.12.013. Epub 2014 Feb 21.

PMID:
24656908
42.

Intra-axonal protein aggregation in the peripheral nervous system.

Vital A, Meissner WG, Canron MH, Martin-Negrier ML, Bezard E, Tison F, Vital C.

J Peripher Nerv Syst. 2014 Mar;19(1):44-9. doi: 10.1111/jns5.12056.

PMID:
24494664
43.

Breathing variability and brainstem serotonergic loss in a genetic model of multiple system atrophy.

Flabeau O, Meissner WG, Ozier A, Berger P, Tison F, Fernagut PO.

Mov Disord. 2014 Mar;29(3):388-95. doi: 10.1002/mds.25804. Epub 2014 Jan 17.

PMID:
24442757
44.

Movement disorders in 2013: diagnosing and treating PD-the earlier the better?

Tison F, Meissner WG.

Nat Rev Neurol. 2014 Feb;10(2):65-6. doi: 10.1038/nrneurol.2013.273. Epub 2014 Jan 7. Review. No abstract available.

PMID:
24394288
45.

Withdrawing amantadine in dyskinetic patients with Parkinson disease: the AMANDYSK trial.

Ory-Magne F, Corvol JC, Azulay JP, Bonnet AM, Brefel-Courbon C, Damier P, Dellapina E, Destée A, Durif F, Galitzky M, Lebouvier T, Meissner W, Thalamas C, Tison F, Salis A, Sommet A, Viallet F, Vidailhet M, Rascol O; NS-Park CIC Network.

Neurology. 2014 Jan 28;82(4):300-7. doi: 10.1212/WNL.0000000000000050. Epub 2013 Dec 26.

PMID:
24371304
46.

Natural history of functional decline in Alzheimer's disease: a systematic review.

Delva F, Auriacombe S, Letenneur L, Foubert-Samier A, Bredin A, Clementy A, Latxague C, Puymirat E, Ballan G, Delabrousse-Mayoux JP, Glénisson L, Mazat L, Spampinato U, Rainfray M, Tison F, Dartigues JF.

J Alzheimers Dis. 2014;40(1):57-67. doi: 10.3233/JAD-131862. Review.

PMID:
24326518
47.

Standard strategies for diagnosis and treatment of patients with newly diagnosed Parkinson disease: FRANCE.

Tison F, Meissner WG.

Neurol Clin Pract. 2013 Dec;3(6):480-481. doi: 10.1212/01.CPJ.0000437017.29917.c9. No abstract available.

48.

Age-related motor dysfunction and neuropathology in a transgenic mouse model of multiple system atrophy.

Fernagut PO, Meissner WG, Biran M, Fantin M, Bassil F, Franconi JM, Tison F.

Synapse. 2014 Mar;68(3):98-106. doi: 10.1002/syn.21719. Epub 2013 Nov 15.

PMID:
24243499
49.

Short and long term outcome of bilateral pallidal stimulation in chorea-acanthocytosis.

Miquel M, Spampinato U, Latxague C, Aviles-Olmos I, Bader B, Bertram K, Bhatia K, Burbaud P, Burghaus L, Cho JW, Cuny E, Danek A, Foltynie T, Garcia Ruiz PJ, Giménez-Roldán S, Guehl D, Guridi J, Hariz M, Jarman P, Kefalopoulou ZM, Limousin P, Lipsman N, Lozano AM, Moro E, Ngy D, Rodriguez-Oroz MC, Shang H, Shin H, Walker RH, Yokochi F, Zrinzo L, Tison F.

PLoS One. 2013 Nov 5;8(11):e79241. doi: 10.1371/journal.pone.0079241. eCollection 2013.

50.

D1 receptor agonist improves sleep-wake parameters in experimental parkinsonism.

Hyacinthe C, Barraud Q, Tison F, Bezard E, Ghorayeb I.

Neurobiol Dis. 2014 Mar;63:20-4. doi: 10.1016/j.nbd.2013.10.029. Epub 2013 Nov 6.

PMID:
24211719

Supplemental Content

Support Center